This technology is a pharmacological intervention targeting localized inflammatory responses in trauma and hemorrhagic shock to prevent multiple organ failure.
This technology is patient-specific engineered model of bone marrow for diagnostics and research of cancer progression using a sample of patient’s serum.
This technology is a bioengineered bone marrow system that can be applied to study various human diseases, toxicity responses, and immune functions in vitro.
This technology is a monoclonal antibody which binds annexin for the inhibition of Funsobacterium nucleatum (Fn) invasion and proliferation to treat and prevent Fn related diseases including colorectal cancer and Familial Adenomatous Polyposis (FAP).
This technology is a method to generate squamous epithelial 3D organoids that can mimic the natural physiology of tissues and be used to model gastrointestinal physiology.
This technology is a nucleic acid-based polymer system that can be engineered to target the expression of specific cancer-associated genes for therapeutic benefit.
This technology is a modular platform with engineered tissues linked by vascular perfusion that can be used to study tumor progression and systemic disease in a clinically relevant setting.
This technology is two methods, called ssg-MeDIP-Seq and sscf-MeDIP-Seq, for improved tumor detection using detection of DNA methylation density in genomic DNA, and of hemi-methylated regions in plasma cell-free DNA.
This technology is a targeted anti-tumor agent designed to treat adenoid cystic carcinoma (ACC) by utilizing retinoid receptor modulation to promote cancer cell differentiation and selective cell death.
This technology is a method of isolating polynucleotides from cell-free non-invasive bodily samples and sequencing them to detect methylated DNA to identify early tumors.
